Project description
Innovative platform for precision drug repurposing
Drug repurposing investigates the use of existing drugs for new therapeutic purposes. Thus, it reduces the time and costs of drug development. However, it is often accidental and less effective than classical drug discovery. Both discovery and repurposing suffer from the same knowledge gap, whereby diseases are not understood from a mechanistic perspective and are treated symptomatically in an imprecise manner. The EU-funded REPO4EU project will establish a comprehensive European/global platform for validated precision drug repurposing open to stakeholders for information, multimedia training, matchmaking and cooperation. The project, consisting of world-leading scientists, will redefine diseases using a mechanism-based approach, applying advanced bioinformatics and AI to real-world Big Data.
Fields of science
- medical and health sciencesbasic medicinepharmacology and pharmacydrug discovery
- natural sciencescomputer and information sciencesdata sciencebig data
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteins
- natural sciencescomputer and information sciencesartificial intelligencemachine learningdeep learning
Keywords
Programme(s)
Funding Scheme
RIA - Research and Innovation action
Coordinator
6200 MD Maastricht
Netherlands
See on map
Participants (26)
82256 Furstenfeldbruck
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
1010 Wien
See on map
80333 Munchen
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
08039 Barcelona
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
20148 Hamburg
See on map
80333 Muenchen
See on map
13353 Berlin
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
69151 Neckargemund
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
28040 Madrid
See on map
73529 Schwabisch Gmund
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
362 91 Tingsryd
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
08860 Castelldefel
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
104 22 Stockholm
See on map
02115 Boston Ma
See on map
53127 Bonn
See on map
1170 Vienna
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
4818 CL Breda
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
520014 Sfantu Gheorghe
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
5026 SK Tilburg
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
6525 GA Nijmegen
See on map
6229 HX Maastricht
See on map
10437 Berlin
See on map
9000 Gent
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
4099-002 Porto
See on map
1181 VX Amstelveen
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partners (1)
8006 Zurich
See on map